Back

Cardiogenetic Registry: Design and first Results on the prevalence of pathogenic variants in cardiomyopathies

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pathophysiology and mechanisms (4) Pathophysiology Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Noel Panagiotides

Medical University of Vienna, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
Hypertensive response to exercise indexed to oxygen consumption: associations with cardio-vascular-renal function and prognosis across the spectrum of heart failure with preserved ejection fraction
Doctor N. De Biase (Pisa, IT)
Abstract Slides
Presentation thumbnail
Impact of non-invasive positive pressure ventilation on pulmonary artery diastolic pressure: a longitudinal physiologic analysis
Doctor R. Germany (Minnetonka, US)
Abstract Slides
Presentation thumbnail
Pilot study on hemodynamic monitoring in patients with advanced heart failure - comparison of non-invasive versus invasive hemodynamic monitoring
Doctor S. Macura (Berlin, DE)
Abstract Slides
Presentation thumbnail
Correlation of NT-proBNP, C-reactive protein, and renal function with left ventricular ejection fraction in HFpEF and HFmrEF
Doctor D. Milosevic (Nis, RS)
Abstract Slides
Presentation thumbnail
Early effects of levosimendan on LV function in patients with CCS and single vessel CTO of the LAD artery
Doctor M. Norkulov (Karshi, UZ)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - pathophysiology and mechanisms (4)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Chronic kidney disease and heart failure
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources